AVITA Medical
RCELMarket price data through October 30, 2026.
Performance
Nov 2021 – Oct 2026
Track record
How this pick has done since Benson first called it.
- Benson Return
- 0%
- How much this stock is up since Benson first picked it — measured from the price at the time of that first pick, not from today.
- First pick price
- ~$16
- Roughly what one share cost when Benson first picked this stock. This is the starting line for the Benson Return.
- Tracking since
- November 2026
- The month this stock first became a Benson pick.
- Tracking duration
- 0 months
- How long Benson has been tracking this pick.
About AVITA Medical
AVITA Medical makes a skin-healing system called RECELL for burns and other serious wounds. Instead of grafting a big sheet of skin from somewhere else on the body, it turns a tiny sample of the patient's own skin into a spray that covers a much larger area. Think of it as growing a lawn from a few handfuls of seed instead of laying down sod.
The case for and against
Both sides of the story, in plain English.
- Record Growth
Quarterly sales hit a record 21.7 million dollars, up 18% from a year ago and up 13% from the quarter before. Gross margins are about 82%, very high for a medical device maker. The company just raised its full year sales forecast to between 86 and 89 million dollars.
- Path To Breakeven
Cash burn fell from 9.9 million dollars to about 3.2 million in a single quarter, and management expects to stop burning cash by the end of this year. Medicare has also proposed a national payment rate for the RECELL procedure starting in 2027, which could make hospitals more comfortable using it.
- Thin Cash Cushion
The company ended the quarter with only about 11.1 million dollars in cash, while owing about 50 million dollars to a lender. It still lost 7.7 million dollars in the quarter, so the plan to break even has to work on schedule.
- Wild Swings
The share price has more than tripled since early August, so a lot of good news is already baked in. Small, still-unprofitable medical companies like this one can move sharply in either direction on a single earnings report or a Medicare decision.
Other companies we track
How to read this page
This automated research summary uses Financial Modeling Prep market data through 2026-10-30. Model signals, scores, and risk labels can change and may be incomplete or wrong.
Want Benson to watch RCEL for you?
Get the app to follow every Benson pick live — and let Benson do the research for you.